5 Key Advances in Parkinson's Neuroshielding 2026

bir ses eklendi Meditasyon ve Farkındalık

2026-01-20 12:14:43 -

With 2026 marking a pivotal year, the European Medicines Agency's revised Parkinson's guidelines are emphasizing neuroprotective interventions to halt alpha-synuclein spread, influenced by global data from ongoing cohorts. This resonates with India's Parkinson's Disease and Movement Disorder Society initiatives, aiming to integrate these advances into routine clinical practice amid aging...

0 Yorumlar 0 hisse senetleri 572 Gösterim 0 Yorumlar